Should total thyroidectomy become the preferred procedure for surgical management of Graves' disease?

被引:73
作者
Lal, G
Ituarte, P
Kebebew, E
Siperstein, A
Duh, QY
Clark, OH
机构
[1] Univ Calif San Francisco, Mt Zion Med Ctr, Dept Surg, San Francisco, CA 94143 USA
[2] Univ Iowa Hosp & Clin, Dept Surg, Iowa City, IA 52242 USA
[3] Vet Affairs Med Ctr, San Francisco, CA 94121 USA
[4] Cleveland Clin Fdn, Dept Gen Surg, Cleveland, OH 44195 USA
关键词
D O I
10.1089/thy.2005.15.569
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aims to evaluate our institution's experience with thyroidectomy for Graves' disease, with an emphasis on indications and long-term outcomes. The study cohort consisted of 103 patients (mean age 34.3 [+/- 13.9] years), who underwent thyroidectomy for Graves' disease between 1991 and 2002. Clinical and follow-up data were obtained by retrospective review of medical records and by contacting treating physicians or patients. The most common surgical indications were patient preference (26%), cold nodule (24%), eye symptoms (20%), large goiter size (18%), allergy to antithyroidal medications (15%), and age younger than 16 years (14%). Thyroidectomies performed included 45 (total or near-total), 57 subtotal, and 1 lobectomy. Transient complications included hypocalcemia in 42 patients, and recurrent laryngeal nerve palsy in 5 patients. There was no difference in the frequency of hypocalcemia in patients undergoing total or subtotal resections. One patient developed permanent hypocalcemia and 2 permanent recurrent laryngeal nerve (RLN) injury. Only 3 patients who underwent subtotal resections remain off thyroxine and 2 developed recurrent hyperthyroidism approximately 17 and 54 months after surgery. Subtotal thyroidectomy is associated with a high rate of hypothyroidism and large remnants have potential for recurrence. Total or near-total thyroidectomy obviates these disadvantages and can be performed without increased complication rates, thus appearing to be the preferred extent of thyroidectomy for Graves' disease.
引用
收藏
页码:569 / 574
页数:6
相关论文
共 27 条
[1]   Treatment of Graves' disease: The advantages of surgery [J].
Alsanea, O ;
Clark, OH .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2000, 29 (02) :321-+
[2]   Total thyroidectomy is now the preferred option for the surgical management of Graves' disease [J].
Barakate, MS ;
Agarwal, G ;
Reeve, TS ;
Barraclough, B ;
Robinson, B ;
Delbridge, LW .
ANZ JOURNAL OF SURGERY, 2002, 72 (05) :321-324
[3]  
CHANG DCS, 1987, SURGERY, V102, P1055
[4]   THE ROLE OF THYROID-STIMULATING ANTIBODIES OF GRAVES-DISEASE IN DIFFERENTIATED THYROID-CANCER [J].
FILETTI, S ;
BELFIORE, A ;
AMIR, SM ;
DANIELS, GH ;
IPPOLITO, O ;
VIGNERI, R ;
INGBAR, SH .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (12) :753-759
[5]   Mortality after the treatment of hyperthyroidism with radioactive iodine [J].
Franklyn, JA ;
Maisonneuve, P ;
Sheppard, MC ;
Betteridge, J ;
Boyle, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (11) :712-718
[6]   Total thyroidectomy for benign thyroid disease [J].
Friguglietti, CUM ;
Lin, CS ;
Kulcsar, MAV .
LARYNGOSCOPE, 2003, 113 (10) :1820-1826
[7]  
Ginsberg J, 2003, CAN MED ASSOC J, V168, P575
[8]  
Hermann H, 1999, SURGERY, V125, P522
[9]   Total thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathy [J].
Kurihara, H .
THYROID, 2002, 12 (03) :265-267
[10]  
Marcocci C, 1999, CLIN ENDOCRINOL, V51, P503